Business

July 7, 2014

BioDelivery Sciences shares rise on positive drug trial results

BioDelivery Sciences International shares were up nearly 15 percent in early trading Monday after the Raleigh company announced positive Phase 3 clinical trial results for its experimental treatment for chronic pain.

Related content

Comments

Videos

Editor's Choice Videos